Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04340817

Fatty Liver Disease in Nordic Countries

A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Non-Alcoholic Fatty Liver Disease Digestive System Diseases Fatty Liver Liver Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non-alcoholic fatty liver disease and
  • Healthy volunteers

Exclusion criteria

  • Other liver diseases than non-alcoholic fatty liver disease
  • Lack of informed consent

Treatment and study plan

Proteomics

Diagnostic Test

Mass-spectometry proteomics

Transcriptomics

Diagnostic Test

Next generation sequencing

Genomics

Genetic

Targeted genetics

Primary outcomes

  1. Fibrosis

    Time frame: 5 years

    Number of participants with fibrosis proression

Study contacts

Contact information is provided by the study sponsor or research team.

Lise L Gluud, MD

CONTACT

[email protected]

+45 38623862

Mikkel P Werge, MD

CONTACT

[email protected]

+45 38623862

Sponsors and collaborators

Lead sponsor

Copenhagen University Hospital, Hvidovre

Other

Registry information

Official study title

Fatty Liver Disease in Nordic Countries (FLINC): a Prospective Cohort Study

Acronym: FLINC

Important dates

Study start
2017
Primary completion
2025
Study completion
2026
First posted
Apr 10, 2020
Registry last updated
Apr 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.